| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADM
|
adrenomedullin
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGR2
|
anterior gradient 2
|
|
AGR3
|
anterior gradient 3
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALX4
|
ALX homeobox 4
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANXA2
|
annexin A2
|
|
APC
|
adenomatous polyposis coli
|
|
APITD1
|
apoptosis-inducing, TAF9-like domain 1
|
|
APLN
|
apelin
|
|
APLP1
|
amyloid beta (A4) precursor-like protein 1
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L15
|
BCL2-like 15
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRK1
|
BRICK1, SCAR/WAVE actin-nucleating complex subunit
|
|
CA12
|
carbonic anhydrase XII
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCR
|
calcitonin receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNH
|
cyclin H
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD34
|
CD34 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD82
|
CD82 molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CHAF1B
|
chromatin assembly factor 1, subunit B (p60)
|
|
CHGA
|
chromogranin A
|
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
|
CLDN18
|
claudin 18
|
|
CLDN3
|
claudin 3
|
|
CLDN8
|
claudin 8
|
|
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
CSK
|
c-src tyrosine kinase
|
|
CSTA
|
cystatin A (stefin A)
|
|
CSTB
|
cystatin B (stefin B)
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSS
|
cathepsin S
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYGB
|
cytoglobin
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
D2HGDH
|
D-2-hydroxyglutarate dehydrogenase
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCD
|
dermcidin
|
|
DCX
|
doublecortin
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DEFB1
|
defensin, beta 1
|
|
DIAPH3
|
diaphanous-related formin 3
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DNAJC15
|
DnaJ (Hsp40) homolog, subfamily C, member 15
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
E2F3
|
E2F transcription factor 3
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA3
|
EPH receptor A3
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAM107A
|
family with sequence similarity 107, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF5
|
fibroblast growth factor 5
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
GABARAPL1
|
GABA(A) receptor-associated protein like 1
|
|
GDF9
|
growth differentiation factor 9
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPR55
|
G protein-coupled receptor 55
|
|
H1FX
|
H1 histone family, member X
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC11
|
histone deacetylase 11
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HELLS
|
helicase, lymphoid-specific
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HYAL2
|
hyaluronoglucosaminidase 2
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IHH
|
indian hedgehog
|
|
IL1A
|
interleukin 1, alpha
|
|
IL2
|
interleukin 2
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INHA
|
inhibin, alpha
|
|
INHBB
|
inhibin, beta B
|
|
IRF5
|
interferon regulatory factor 5
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB6
|
integrin, beta 6
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLK1
|
kallikrein 1
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT7
|
keratin 7, type II
|
|
L2HGDH
|
L-2-hydroxyglutarate dehydrogenase
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LMO4
|
LIM domain only 4
|
|
LMX1A
|
LIM homeobox transcription factor 1, alpha
|
|
LTF
|
lactotransferrin
|
|
LUZP4
|
leucine zipper protein 4
|
|
LYPD3
|
LY6/PLAUR domain containing 3
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MB
|
myoglobin
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED12
|
mediator complex subunit 12
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR10B
|
microRNA 10b
|
|
MIR143
|
microRNA 143
|
|
MIR155
|
microRNA 155
|
|
MIR18B
|
microRNA 18b
|
|
MIR200B
|
microRNA 200b
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR221
|
microRNA 221
|
|
MIR29C
|
microRNA 29c
|
|
MIR371A
|
microRNA 371a
|
|
MIR372
|
microRNA 372
|
|
MIR373
|
microRNA 373
|
|
MIR379
|
microRNA 379
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR92A1
|
microRNA 92a-1
|
|
MIR92A2
|
microRNA 92a-2
|
|
MIRLET7B
|
microRNA let-7b
|
|
MIRLET7G
|
microRNA let-7g
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MVP
|
major vault protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYEOV
|
myeloma overexpressed
|
|
NANOG
|
Nanog homeobox
|
|
NBN
|
nibrin
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NES
|
nestin
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRBP1
|
nuclear receptor binding protein 1
|
|
NSUN2
|
NOP2/Sun RNA methyltransferase family, member 2
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
|
ORAOV1
|
oral cancer overexpressed 1
|
|
P4HTM
|
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARVB
|
parvin, beta
|
|
PBRM1
|
polybromo 1
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PERP
|
PERP, TP53 apoptosis effector
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PFN2
|
profilin 2
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLQ
|
polymerase (DNA directed), theta
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R13B
|
protein phosphatase 1, regulatory subunit 13B
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRLR
|
prolactin receptor
|
|
PROM1
|
prominin 1
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAD51
|
RAD51 recombinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RLN1
|
relaxin 1
|
|
RNF4
|
ring finger protein 4
|
|
RNF43
|
ring finger protein 43
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RSPO2
|
R-spondin 2
|
|
RSPO3
|
R-spondin 3
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SATB1
|
SATB homeobox 1
|
|
SATB2
|
SATB homeobox 2
|
|
SCG2
|
secretogranin II
|
|
SCG3
|
secretogranin III
|
|
SCG5
|
secretogranin V
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SDC3
|
syndecan 3
|
|
SDC4
|
syndecan 4
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEPT2
|
septin 2
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHH
|
sonic hedgehog
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNRPN
|
small nuclear ribonucleoprotein polypeptide N
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP3
|
Sp3 transcription factor
|
|
SPATA2
|
spermatogenesis associated 2
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SST
|
somatostatin
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
SULF2
|
sulfatase 2
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOX3
|
TOX high mobility group box family member 3
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
UBE2Q2
|
ubiquitin-conjugating enzyme E2Q family member 2
|
|
UQCC1
|
ubiquinol-cytochrome c reductase complex assembly factor 1
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VRK1
|
vaccinia related kinase 1
|
|
WDR76
|
WD repeat domain 76
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WNK2
|
WNK lysine deficient protein kinase 2
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
ZDHHC14
|
zinc finger, DHHC-type containing 14
|
|
ZMYND10
|
zinc finger, MYND-type containing 10
|
|
ZNF146
|
zinc finger protein 146
|
|
ZNF185
|
zinc finger protein 185 (LIM domain)
|
